SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

TD1 TALi Digital Limited

Healthcare · Health Information Services · website
$0.08
52wk 0.04 – 0.15
Overall
71.7
Value
75.1
Growth
100.0
Health
98.8
Quality
0.0
Momentum
65.2
Dividend
—
Price
About TALi Digital Limited

TALi Digital Limited, a digital health company, delivers diagnostic and therapeutic solutions to enhance attention cognitive function in Australia, New Zealand, and internationally. It offers ReadyAttentionGo!, a medical device that is a digital therapeutic cognitive training program designed to improve attention skills in children aged 3 to 10 years old; TALi Research and Development!; and You Can Do It! Education, an online social-emotional learning and mental health program for children and adolescents. The company was formerly known as Novita Healthcare Limited and changed its name to TALI Digital Limited in December 2019. TALi Digital Limited was incorporated in 2004 and is based in Hawthorn East, Australia.

Price analytics

Returns

1 day 0.0%
1 week -11.4%
1 month -13.3%
3 months 23.8%
6 months 81.4%
1 year -48.0%
3 years -22.0%

Risk

Volatility (1y ann.) 102.6%
Beta vs ASX 200 0.42
Sharpe (1y) -0.18
VaR 95% (1-day) -9.1%
Max drawdown (1y) -60.0%
Off 1-year high -32.2%

Technicals

RSI(14) 23 OS
vs 50DMA -13.8%
vs 200DMA 21.7%
Trend Golden cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 75.1
Trailing P/E
—
Forward P/E
—
PEG ratio
90
EV / EBITDA
100
Price / Book
89
Price / Sales
0
Growth 100.0
Revenue growth (1y)
100
Revenue CAGR (3y)
100
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 98.8
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
99
Debt / Equity
—
Quality (Profitability & Cash Flow) 0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 65.2
6-month return vs ASX 200
100
Price vs 200-day average
100
Price vs 50-day average
0
Position in 52-week range
34

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$10.51M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
-0.05
Dividend yield
—
Payout ratio
0.0%
Beta
1.28
EV / EBITDA
-2.77
Price / Book
1.59
ROE
-151.8%
Operating margin
-253.1%
Net margin
0.0%
Total cash
$977,819
Total debt
$0
Current ratio
2.48
Debt / Equity
—
Free cash flow
$-303,155
Avg volume
57,728
Latest annual results (FY ending 30 Jun 2026)
  • Revenue$233.08K
  • Gross profit$186.34K
  • Operating income-$1.14M
  • Net income-$2.21M
  • Diluted EPS—
  • Free cash flow-$737.32K
  • Net debt-$973.79K
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $84.15B — 54.3
RMD $45.86B 21.2 74.4
SIG $29.91B 43.3 55.6
FPH $21.64B 57.5 71.1
PME $16.34B 61.8 69.0
RHC $12.56B 40.0 40.2
SHL $9.12B 15.0 43.0
COH $8.20B 55.5 39.4